News

Medable Partners with Google Cloud for Enhanced Clinical Trials

Medable Partners with Google Cloud for Enhanced Clinical Trials

Medable and Google Cloud Create Synergy for Clinical Trials

Medable Inc., a top provider of clinical development technology, is thrilled to announce a new partnership with Google Cloud. This collaboration aims to introduce Medable’s Digital and Decentralized Clinical Trial Platform to the Google Cloud Marketplace. By leveraging Google Cloud’s powerful infrastructure and AI capabilities, customers will enjoy seamless integration with Medable’s advanced platform, which is particularly noted for its new SaaS solution, Studio. This initiative will support pharmaceutical companies in achieving greater control and transparency in the processes of clinical trial design, deployment, and management.

Enhanced Accessibility through Google Cloud Marketplace

The Google Cloud Marketplace is renowned for offering integrated solutions that meet the enterprise IT needs of its customers. Enterprises actively seek out Google Cloud Marketplace for third-party tools that allow them to build on and effectively use Google Cloud services. Through the ease of access provided by the marketplace, customers purchasing Medable solutions will enjoy consolidated billing. This means that usage of Medable services will appear straightforwardly on Google Cloud invoices, streamlining the billing process significantly.

Transforming Clinical Development with AI

The partnership stands to benefit clinical trial sponsors greatly. By harnessing the power of AI and advanced cloud technologies, clinical trial design, execution, and data management can be accelerated. Now, customers can take full advantage of Medable’s latest innovations across their enterprise and hybrid cloud environments, ensuring optimal efficiency and effectiveness in clinical trials.

Leaders in Clinical Technology Collaboration

Dr. Michelle Longmire, co-founder and CEO of Medable, highlighted the significance of this collaboration. She stated, "This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace. This collaboration will foster the broad adoption of Medable solutions among Google Cloud users, paving the way for improved patient access to clinical trials and accelerating imperative development efforts on a global scale." Such sentiments reflect a strong commitment to enhancing the clinical landscape through innovative technology solutions.

Impressive Achievements by Medable

Medable’s reputation continues to grow, especially as it ranks in the top 8% of software companies on the recent Inc. 5000 list. The company has successfully implemented its platform in over 300 decentralized and hybrid clinical trials across 60 countries, thereby serving more than a million patients and research participants worldwide. Noteworthy results include achieving 200 percent faster enrollment rates and cost reductions up to 50 percent. Research from Tufts CSDD has shown that decentralized clinical trials can yield considerable financial benefits, often providing a return on investment significantly exceeding initial costs.

Future Events and Learning Opportunities

Industry professionals can gain further insights into the advantages of Medable’s collaboration with Google Cloud at the upcoming Cancer AI Symposium. Scheduled for a soon-approaching date, this event will feature Dr. Michelle Longmire as a speaker, providing an excellent opportunity for attendees to learn about the cutting-edge innovations in clinical trials.

The Mission of Medable

At its core, Medable remains devoted to accelerating the delivery of effective therapies to patients. Its digital clinical trials platform is designed to enhance speed, scalability, and patient access, ultimately aiming to address myriad medical conditions still in search of treatment or cure. Recognized as the Best Digital Health Solution by the Galien Foundation, Medable’s platform has facilitated nearly 400 trials in 70 countries across 120 languages, positively impacting over a million patients globally. As a privately-held and venture-backed enterprise, the company continues to thrive, reflecting its commitment to transforming clinical development for improved patient outcomes.

Frequently Asked Questions

What is the purpose of Medable's partnership with Google Cloud?

The partnership aims to bring innovative clinical trial technology to the Google Cloud Marketplace, enhancing overall efficiency and accessibility for clients.

How does the Google Cloud Marketplace benefit Medable's customers?

Customers can easily access consolidated billing and streamlined procurement for Medable services, simplifying financial management.

What are some key achievements of Medable?

Medable has led over 300 decentralized trials, achieving rapid enrollment and significant cost savings, impacting over one million patients worldwide.

Will there be events related to Medable's collaboration with Google Cloud?

Yes, Medable will participate in the Cancer AI Symposium where insights on the collaboration will be shared.

What is Medable's mission?

Medable is dedicated to accelerating the availability of effective therapies by improving clinical trial speed, scale, and patient access.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Southern Home Services Grows Houston Base With New Buy

Updated Category News Views 46

Cracking Open the Houston Market If you're sniffing out a story in the HVAC and plumbing sector, look no further than Southern Home Services' latest acquisition. They've just scooped up Vanderford Air and Plumbing in League City, Texas, and this ain't small potatoes, folks. This move marks Southern's second foothold in the Houston DMA, giving them some real skin in the...

Continue Reading
Everest Group Faces Class Action for Misleading Investors

Updated Category News Views 15

What Went Awry with Everest Group? Alright, folks, let's chew through the latest stock rumble hitting the wires: Everest Group, Ltd. (NYSE: EG) has a hefty class-action lawsuit tossed its way, courtesy of DJS Law Group. Now, if you're scratching your head trying to piece this together, you're not alone. This isn't just some minor hiccup; we're talking allegations of...

Continue Reading
Katie Lee: Embracing Losses for Business Success

Updated Category News Views 162

Redefining Adversity Through Business Acumen You'd think building a business empire requires nothing short of pure triumph, yet Katie Lee sings a different tune altogether. Lee's path from high school dropout to a prominent figure in the culinary world is paved with setbacks—albeit ones she wears like badges of honor. This November 18th, catch her at the New York Public...

Continue Reading
Everest Group Faces Shaky Ground in Securities Fraud Suit

Updated Category News Views 76

Investors Take Aim at Everest Group's Alleged Missteps Looks like Everest Group, Ltd. (NYSE: EG) has found itself knee-deep in legal quicksand. There's a class-action lawsuit afoot, spearheaded by the folks at Schall, Brown & Schwartz LLP. They're putting forward claims that Everest, a player in the securities exchange, was painting a misleading picture when it came to...

Continue Reading
Yum China Delivers Strong Q3 2026 Results Again

Updated Category News Views 93

A Steady March Forward for Yum China Yum China's third-quarter results reveal a company moving like a well-oiled machine, even in a turbulent market. A revenue uptick of 8% is no small feat, especially when operating under the weight of a 3% rise in system sales that neatly sidesteps the usual foreign exchange hiccups. This ain't just about keeping the lights on; it's...

Continue Reading
FileInvite Transforms Complex Lending with Bold Platform Relaunch

Updated Category News Views 66

A New Era for Lending Documentation If you've been drumming your fingers waiting on loan paperwork to get sorted, FileInvite's latest move might just be the caffeine kick the lending world needs. Announced at the NAGGL Annual Conference, their souped-up platform has been redesigned as the beating heart of lending documentation. This isn't just a facelift folks—it's an...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 76

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
AMETEK Surpasses Q3 2026 Expectations, Raises Outlook

Updated Category News Views 94

A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...

Continue Reading
Felicitysolar's Global Reach and R&D Highlights

Updated Category News Views 92

Celebrating Partnerships and Achievements Felicitysolar ain't your run-of-the-mill energy outfit. On October 17, 2026, they rolled out the red carpet—or perhaps better put, the Pearl River—for their international distributors in Guangzhou. An event dubbed "Felicity Together — Together, We Create More" left no doubt that these folks are in it for the long haul with...

Continue Reading
Seaboard's Q3 Financials: A Mixed Bag for Investors

Updated Category News Views 87

Eyeing Seaboard's Earnings: What's the Deal? Seaboard Corporation just dropped its earnings report for the third quarter, and boy, it's a doozy. The numbers show a mixed bag—like finding out your favorite team won, but your best player got benched with an injury. On the surface, we've got a rise in net sales, but dig a little deeper, and the cracks start to show. Sales...

Continue Reading

Top 5 Most Recently Viewed Articles

RadNet Unveils Exciting Agenda for Upcoming Investor Day Event

Updated Category News Views 139

RadNet's Investor Day: An Overview RadNet, Inc. (NASDAQ: RDNT), an industry leader in providing top-quality diagnostic imaging services, has announced the agenda for its upcoming Investor Day. This special event represents a significant opportunity for shareholders and investors to engage directly with RadNet’s leadership and learn more about the company's innovations...

Continue Reading
Understanding the Fluor Corporation Investigation for Investors

Updated Category News Views 196

Understanding the Fluor Corporation Investigation for Investors Investors of Fluor Corporation are currently facing a significant situation that has come to light regarding potential violations of securities laws. The DJS Law Group is stepping in to explore claims against Fluor Corporation (NYSE: FLR) as part of its investigative efforts. Background of the Investigation...

Continue Reading
O'Reilly Automotive Unveils Earnings Release and Conference Call Dates

Updated Category News Views 117

O'Reilly Automotive Schedules Q2 2025 Earnings Announcement O'Reilly Automotive, Inc. has announced significant details regarding its upcoming financial updates for the second quarter of 2025. This essential release is set to happen on a Wednesday, which will mark a key moment for investors and stakeholders alike. The company, a prominent player in the automotive...

Continue Reading
Exploring the Growth of Research-Grade Proteins by 2034

Updated Category News Views 126

Understanding the Surge in Research-Grade Proteins Market Recent analysis shows a promising future for the global research-grade proteins market. This sector is on a trajectory to soar from USD 1.13 billion in the early 2024 to an impressive USD 4.81 billion by 2034. The anticipated growth rate stands at a remarkable compound annual growth rate (CAGR) of 15.57%,...

Continue Reading
Twilio's Strategic Partnership Drives Stock Momentum

Updated Category News Views 252

Twilio's Growth Strategy and Recent Developments Twilio Inc (NYSE: TWLO) has recently made headlines by announcing a groundbreaking multi-year partnership with a prominent national sports team, the LA Kings. This strategic alliance is the company's first major foray into sports sponsorship at the professional level, showcasing its commitment to expanding its brand...

Continue Reading